Australia updates GLP-1 warnings concerning a rare eye disorder
TGA added information about non-arteritic anterior ischaemic optic neuropathy; the change applies to the Australian market.
Read story →Documented updates
Obesity and GLP-1 treatment news
Regulatory changes, safety and research explained with primary sources and visible limitations.
Canada authorises its first generic semaglutide for weight management
Health Canada authorised Sevmia as a Wegovy generic; the Canadian decision does not establish availability or approval elsewhere.
Read story →Observational study compares GLP-1 medicines with bariatric surgery in routine care
The two-system analysis found long-term weight differences, but treatment was not randomly assigned.
Read story →